Details of the Drug Reposition

General Information of This Drug (ID: DMYW8UN)

Drug Name
MMR   DMYW8UN
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Mumps virus infection DIS08HIJ 1D80 Phase 3 [1]
Rubella prophylaxis DIS4TDCK 1F02 Phase 3 [1]
Measles DISXSUID 1F03 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02184572) Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine inHealthy Children 12 to 15 Months of Age. U.S. National Institutes of Health.